SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.
Di Mambro A, Arroyo-Berdugo Y, Fioretti T, Randles M, Cozzuto L, Rajeeve V, Cevenini A, Austin MJ, Esposito G, Ponomarenko J, Lucas CM, Cutillas P, Gribben J, Williams O, Calle Y, Patel B, Esposito MT.
Di Mambro A, et al. Among authors: randles m.
Oncogene. 2023 Dec;42(50):3670-3683. doi: 10.1038/s41388-023-02840-1. Epub 2023 Oct 27.
Oncogene. 2023.
PMID: 37891368
Free PMC article.